Diagnostic delay in axial spondyloarthritis: demographic, socioeconomic, and healthcare barriers in the West Bank, Palestine
摘要
Diagnostic delay in axial spondyloarthritis (axSpA) worsens outcomes and increases costs, yet evidence from low-resource settings is scarce. We aimed to quantify diagnostic delay in Palestine and test the hypothesis that referral pathway and socioeconomic factors are independently associated with prolonged delay.
MethodWe conducted a cross-sectional study (July–November 2024) across rheumatology clinics in the West Bank. Adults fulfilling ASAS criteria for axSpA were enrolled via structured interviews. Diagnostic delay was defined as years from symptom onset to confirmed diagnosis. Non-parametric tests and Spearman correlations explored univariable associations. Prolonged delay was prespecified as ≥ 6 years and evaluated using multivariable logistic regression. Exploratory patient phenotypes were derived with Partitioning Around Medoids clustering.
ResultsSeventy-nine patients were included (73% male; mean age 43.0 ± 12.2 years). Mean diagnostic delay was 6.37 ± 5.8 years (median 5). On univariable analyses, longer delay was associated with older age, lower education, low income, first contact with a general practitioner (GP), HLA-B27 negativity/unknown status, and absence of reduced spinal mobility. In multivariable models, GP first contact independently increased the odds of prolonged delay (OR 3.69, 95% CI 1.04–13.11; p = 0.044), while reduced spinal mobility was associated with shorter diagnostic delay (OR 0.16, 95% CI 0.03–0.70; p = 0.016). Clustering identified three diagnostic phenotypes; the longest delays occurred among patients with low education/income and GP-first referral.
ConclusionsPalestinian patients with axSpA experience an average diagnostic delay exceeding six years, comparable to global estimates. Referral pathway is the principal modifiable barrier, whereas overt clinical signs (reduced spinal mobility) may trigger earlier recognition. Targeted GP education, streamlined referral protocols, and improved access to HLA-B27 testing are priorities for reducing delay in low-resource settings.